Pacific Biosciences of California (PACB) — Cash Flow-to-Debt Ratio
Pacific Biosciences of California (PACB) has a Cash Flow-to-Debt Ratio of -0.10x as of June 2026, meaning its operating cash flow of $-80.27 Million could theoretically repay 0% of its total liabilities ($785.06 Million) in one year. See how financially flexible is Pacific Biosciences of California to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pacific Biosciences of California Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Pacific Biosciences of California across 18 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Pacific Biosciences of California.
Annual Cash Flow-to-Debt Ratio for Pacific Biosciences of California (2008–2025)
Year-by-year debt coverage analysis for Pacific Biosciences of California. Check how high is Pacific Biosciences of California's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-111.21 Million | $778.73 Million | ▲ +47.8% |
| 2024 | -0.27x | $-206.06 Million | $753.85 Million | ▼ -7.1% |
| 2023 | -0.26x | $-266.55 Million | $1.04 Billion | ▼ -16.7% |
| 2022 | -0.22x | $-263.21 Million | $1.20 Billion | ▼ -139.1% |
| 2021 | -0.09x | $-111.18 Million | $1.22 Billion | ▼ -136.8% |
| 2020 | 0.25x | $19.50 Million | $78.49 Million | ▲ +129.5% |
| 2019 | -0.84x | $-78.31 Million | $93.07 Million | ▲ +28.8% |
| 2018 | -1.18x | $-66.43 Million | $56.21 Million | ▼ -1.5% |
| 2017 | -1.16x | $-67.52 Million | $57.98 Million | ▲ +8.8% |
| 2016 | -1.28x | $-67.93 Million | $53.22 Million | ▼ -53.4% |
| 2015 | -0.83x | $-47.89 Million | $57.57 Million | ▼ -12.5% |
| 2014 | -0.74x | $-51.47 Million | $69.57 Million | ▼ -66.2% |
| 2013 | -0.45x | $-29.83 Million | $67.00 Million | ▲ +88.2% |
| 2012 | -3.78x | $-76.82 Million | $20.30 Million | ▲ +1.3% |
| 2011 | -3.83x | $-102.97 Million | $26.85 Million | ▲ +18.6% |
| 2010 | -4.71x | $-122.00 Million | $25.88 Million | ▼ -1652.4% |
| 2009 | -0.27x | $-74.84 Million | $278.22 Million | ▼ -45.0% |
| 2008 | -0.19x | $-38.30 Million | $206.50 Million | — |